Diagnostic characteristics of S100A8/A9 in a multicenter study of patients with acute right lower quadrant abdominal pain

Academic Emergency Medicine

Volumn 19, Issue 1, 2012, Pages 48-55

  Mills, Angela M ^a   Huckins, David S ^b   Kwok, Heemun ^c   Baumann, Brigitte M ^d   Ruddy, Richard M ^e   Rothman, Richard E ^f   Schrock, Jon W ^g   Lovecchio, Frank ^h   Krief, William I ⁱ   Hexdall, Aaron ^j   Caspari, Robert ^k   Cohen, Beth ^k   Lewis, Roger J ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NEWTON WELLESLEY HOSPITAL   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g METROHEALTH MEDICAL CENTER   (United States)

^h MARICOPA MEDICAL CENTER   (United States)

ⁱ LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^j Department of Emergency Medicine   (United States)

^k AspenBio Pharma Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; CALGRANULIN A; CALGRANULIN B;

ACUTE APPENDICITIS; ACUTE RIGHT LOWER QUADRANT ABDOMINAL PAIN; ADOLESCENT; ADULT; APPENDECTOMY; ARTICLE; DOUBLE BLIND PROCEDURE; EMERGENCY WARD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOWER ABDOMINAL PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PLASMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ABDOMINAL PAIN; ADOLESCENT; ADULT; APPENDECTOMY; APPENDICITIS; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; DOUBLE-BLIND METHOD; EMERGENCY SERVICE, HOSPITAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; LINEAR MODELS; MALE; MASS SCREENING; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84855998297     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2011.01259.x     Document Type: Article

References (30)

1. Pitts SR, Niska RW, Xu J, Burt CW,. National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary. Natl Health Stat Report. 2008: 1-38.
2. Wagner JM, McKinney WP, Carpenter JL,. Does this patient have appendicitis? JAMA. 1996; 276: 1589-94. (Pubitemid 26384742)
3. Rusnak RA, Borer JM, Fastow JS,. Misdiagnosis of acute appendicitis: common features discovered in cases after litigation. Am J Emerg Med. 1994; 12: 397-402. (Pubitemid 24215771)
4. US Government Accountability Office. Medicare Part B Imaging Services: Rapid Spending Growth and Shift to Physician Offices Indicate Need for CMS to Consider Additional Management Practices. Washington, DC: US Government Accountability Office, Publication GAO-08-452. Available at:. Accessed Oct 25, 2011.
5. Gottlieb RH, La TC, Erturk EN, et al., CT in detecting urinary tract calculi: influence on patient imaging and clinical outcomes. Radiology. 2002; 225: 441-9. (Pubitemid 35239245)
6. Pines JM,. Trends in the rates of radiography use and important diagnoses in emergency department patients with abdominal pain. Med Care. 2009; 47: 782-6.
7. Paajanen H, Mansikka A, Laato M, Ristamaki R, Pulkki K, Kostiainen S,. Novel serum inflammatory markers in acute appendicitis. Scand J Clin Lab Invest. 2002; 62: 579-84. (Pubitemid 36071957)
8. Murphy CG, Glickman JN, Tomczak K, et al., Acute appendicitis is characterized by a uniform and highly selective pattern of inflammatory gene expression. Mucosal Immunol. 2008; 1: 297-308. (Pubitemid 351850536)
9. Kentsis A, Lin YY, Kurek K, et al., Discovery and validation of urine markers of acute pediatric appendicitis using high-accuracy mass spectrometry. Ann Emerg Med. 2010; 55: 62-70.
10. Apak S, Kazez A, Ozel SK, Ustundag B, Akpolat N, Kizirgil A,. Spot urine 5-hydroxyindoleacetic acid levels in the early diagnosis of acute appendicitis. J Pediatr Surg. 2005; 40: 1436-9. (Pubitemid 41248007)
11. Bolandparvaz S, Vasei M, Owji AA, et al., Urinary 5-hydroxy indole acetic acid as a test for early diagnosis of acute appendicitis. Clin Biochem. 2004; 37: 985-9. (Pubitemid 39388660)
12. Kafetzis DA, Velissariou IM, Nikolaides P, et al., Procalcitonin as a predictor of severe appendicitis in children. Eur J Clin Microbiol Infect Dis. 2005; 24: 484-7. (Pubitemid 41124502)
13. Rivera-Chavez FA, Peters-Hybki DL, Barber RC, et al., Innate immunity genes influence the severity of acute appendicitis. Ann Surg. 2004; 240: 269-77. (Pubitemid 38963018)
14. Passey RJ, Xu K, Hume DA, Geczy CL,. S100A8: emerging functions and regulation. J Leukoc Biol. 1999; 66: 549-56. (Pubitemid 29489878)
15. Striz I, Trebichavsky I,. Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res. 2004; 53: 245-53. (Pubitemid 38797280)
16. Foell D, Wittkowski H, Vogl T, Roth J,. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol. 2007; 81: 28-37. (Pubitemid 46021248)
17. Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I,. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000; 119: 15-22. (Pubitemid 30452574)
18. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I,. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology. 2002; 123: 450-60. (Pubitemid 34827189)
19. Roseth AG, Aadland E, Grzyb K,. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease. Scand J Gastroenterol. 2004; 39: 1017-20. (Pubitemid 39388470)
20. Fagerberg UL, Loof L, Lindholm J, Hansson LO, Finkel Y,. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007; 45: 414-20. (Pubitemid 350307158)
21. Summerton CB, Longlands MG, Wiener K, Shreeve DR,. Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol. 2002; 14: 841-5. (Pubitemid 34913581)
22. Bealer JF, Colgin M,. S100A8/A9: a potential new diagnostic aid for acute appendicitis. Acad Emerg Med. 2010; 17: 333-6.
23. Brown TW, McCarthy ML, Kelen GD, Levy F,. An epidemiologic study of closed emergency department malpractice claims in a national database of physician malpractice insurers. Acad Emerg Med. 2010; 17: 553-60.
24. Brenner DJ, Hall EJ,. Computed tomography - an increasing source of radiation exposure. N Engl J Med. 2007; 357: 2277-84. (Pubitemid 350190758)
25. Mentes O, Eryilmaz M, Harlak A, et al., Can D-dimer become a new diagnostic parameter for acute appendicitis? Am J Emerg Med. 2009; 27: 765-9.
26. Hernandez R, Jain A, Rosiere L, Henderson SO,. A prospective clinical trial evaluating urinary 5-hydroxyindoleacetic acid levels in the diagnosis of acute appendicitis. Am J Emerg Med. 2008; 26: 282-6. (Pubitemid 351389648)
27. Berni Canani R, Rapacciuolo L, Romano MT, et al., Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig Liver Dis. 2004; 36: 467-70. (Pubitemid 41115450)
28. Shastri YM, Bergis D, Povse N, et al., Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea. Am J Med. 2008; 121: 1099-106.
29. Hammer HB, Odegard S, Syversen SW, et al., Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis. Ann Rheum Dis. 2010; 69: 150-4.
30. Kline JA, Nelson RD, Jackson RE, Courtney DM,. Criteria for the safe use of D-dimer testing in emergency department patients with suspected pulmonary embolism: a multicenter US study. Ann Emerg Med. 2002; 39: 144-52. (Pubitemid 34118944)